In our cell viability assay, we used DOX-selected U2OSR2 and KHOSR2 osteosarcoma cells that have been extensively characterized as having both a stable MDR phenotype and PGP1 overexpression, consistent with previous reports (Ye et al., 2016). Here, CD44 is linked to osteosarcoma.